Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Citi
Medtronic
McKinsey
Chubb
UBS
McKesson
Colorcon
Merck

Generated: April 26, 2018

DrugPatentWatch Database Preview

Rimexolone - Generic Drug Details

« Back to Dashboard

What are the generic sources for rimexolone and what is the scope of rimexolone patent protection?

Rimexolone
is the generic ingredient in one branded drug marketed by Alcon and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for rimexolone. One supplier is listed for this compound.
Summary for rimexolone
Pharmacology for rimexolone
Synonyms for rimexolone
(10R,11S,13S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(11 beta,16 alpha,17 beta)-11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one
(11|A,16|A,17|A)-11-Hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one
(11beta,16alpha,17beta)-11-Hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one
(2R,13R,14S,15S,17S)-17-hydroxy-2,13,14,15-tetramethyl-14-propanoyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one
(2R,13R,14S,15S,17S)-17-HYDROXY-2,13,14,15-TETRAMETHYL-14-PROPANOYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-5-ONE
(8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
11 beta-hydroxy-16 alpha,17 alpha,21-trimethylpregna-1,4-diene-3,20-dione
11|A-Hydroxy-16|A,17,21-trimethylpregna-1,4-diene-3,20-dione
11|A-Hydroxy-16|A,17|A,21-trimethyl-5|A-pregna-1,4-diene-3,20-dione
11beta-Hydroxy-16alpha,17,21-trimethyl-1,4-pregnadien-3,20-dion
11beta-Hydroxy-16alpha,17alpha-dimethyl-17-propionylandrosta-1,4-dien-3-one
49697-38-3
697R383
AB00514006
AC1L21UA
AC1NSKKX
AL 02178
AL-2178
AN-41502
Androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11beta,16alpha,17beta)-
BDBM50103606
BPBio1_001297
BRD-K31627533-001-03-8
BSPBio_001179
C24H34O3
CCG-221020
CHEBI:135566
CHEMBL111461
CHEMBL1200617
D05729
D0D2TN
DB00896
GTPL7099
HMS1571K21
HMS2098K21
HMS2235B18
LS-19341
MLS002154105
NCGC00179273-01
O7M2E4264D
Org 6216
Org-6216
PL007336
Prestwick0_001020
Prestwick1_001020
Prestwick2_001020
Prestwick3_001020
Rimexel
Rimexolon
Rimexolona
Rimexolona [INN-Spanish]
Rimexolone (sustained release intra-articular steroid suspension, Plexis, arthritis)
Rimexolone (USP/INN)
Rimexolone [USAN:BAN:INN]
Rimexolone [USAN:USP:INN:BAN]
Rimexolonum
Rimexolonum [INN-Latin]
SCHEMBL1651214
SCHEMBL445300
SMR001233413
SPBio_003050
SR-01000841221
SR-01000841221-2
Trimexolone
UNII-O7M2E4264D
Vexol
Vexol (TN)
ZINC3945984

US Patents and Regulatory Information for rimexolone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon VEXOL rimexolone SUSPENSION/DROPS;OPHTHALMIC 020474-001 Dec 30, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for rimexolone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon VEXOL rimexolone SUSPENSION/DROPS;OPHTHALMIC 020474-001 Dec 30, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Julphar
Accenture
UBS
Fish and Richardson
Baxter
Healthtrust
QuintilesIMS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.